Azstarys is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in individuals aged 13 and older [1]. It is a central nervous system stimulant containing two active ingredients: serdexymethylphenidate and dexmethylphenidate [1]. Serdexmethylphenidate is a prodrug that is converted to dexmethylphenidate in the body [1].
What is the difference between Azstarys and other ADHD medications?
Azstarys contains both a prodrug and an immediate-release form of dexmethylphenidate, which is designed to provide rapid symptom control [1]. This dual-release mechanism is intended to offer both quick onset and extended coverage of ADHD symptoms [1]. Other ADHD medications may use different stimulant compounds or non-stimulant mechanisms of action.
How does Azstarys work?
Azstarys works by increasing the levels of certain neurotransmitters, primarily dopamine and norepinephrine, in the brain [1]. These neurotransmitters play a role in attention, focus, and impulse control [1]. The prodrug, serdexmethylphenidate, is hydrolyzed in the gastrointestinal tract and blood into dexmethylphenidate, which is the active form that affects the brain [1].
What are the potential side effects of Azstarys?
Common side effects associated with Azstarys include decreased appetite, insomnia, weight loss, nausea, anxiety, irritability, and increased blood pressure [1]. Serious side effects can include cardiovascular problems, psychiatric issues such as new or worsening behavior and thought disorders, and circulation problems [1]. It is important to discuss any concerns with a healthcare provider.
When does Azstarys patent expire?
Information regarding the patent expiry of Azstarys can be found on specialized drug patent databases. According to DrugPatentWatch.com, patent information for Azstarys is available [2]. Specific expiry dates can be influenced by various factors, including patent filings, extensions, and potential legal challenges.
Who manufactures Azstarys?
Azstarys is manufactured by Corium, Inc. [1]. Corium is a pharmaceutical company focused on developing and commercializing prescription drug products.
What are the approved uses for Azstarys?
Azstarys is approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years of age and older [1]. It is intended to be used as part of a comprehensive treatment program for ADHD that may include psychological, educational, and social interventions.
What clinical data supports the use of Azstarys?
Clinical trials for Azstarys have evaluated its efficacy and safety in treating ADHD in adolescents and adults. These studies typically assess symptom reduction through various rating scales and monitor for adverse events [1].
---
Cited Sources:
1. https://www.azstarys.com/
2. https://drugpatentwatch.com/